---
title: "Cobenfy (xanomeline and trospium chloride) in schizophrenia: Indication questions"
description: "Indication questions on Cobenfy (xanomeline and trospium chloride) in schizophrenia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is COBENFY (xanomeline and trospium chloride) approved to treat? What is the generic name of COBENFY? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/cobenfy--schizophrenia/indication"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Cobenfy (xanomeline and trospium chloride) in schizophrenia: Indication questions

Manufacturer: Bristol-Myers Squibb Company  
Prescribing information: [Cobenfy](https://packageinserts.bms.com/pi/pi_cobenfy.pdf)

## Indication

<a id="cobenfy-adult-indication"></a>

### What is COBENFY (xanomeline and trospium chloride) approved to treat?

> “COBENFY<sup>™</sup> (xanomeline and trospium chloride) is indicated for the treatment of schizophrenia in adults.”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) | For HCPs, captured 2026-11-08](https://www.cobenfyhcp.com/#:~:text=%28xanomeline%20and%20trospium%20chloride%29%20is%20indicated,treatment%20of%20schizophrenia%20in%20adults.)

## Drug names

<a id="cobenfy-generic-name"></a>

### What is the generic name of COBENFY?

> “COBENFY™ (xanomeline and trospium chloride) capsules, for oral use”

Source: [COBENFY: Prescribing information, page 1, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_cobenfy.pdf#page=1)

## Related pages
- [Medical information: Cobenfy (xanomeline and trospium chloride): Schizophrenia](https://www.evicenter.com/medical-information/cobenfy--schizophrenia)
- [Pharmacology](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/access-and-coverage)
